Literature DB >> 15894153

Keeping up with evidence a new system for WHO's evidence-based family planning guidance.

Anshu P Mohllajee1, Kathryn M Curtis, Richard G Flanagan, Ward Rinehart, Mary Lyn Gaffield, Herbert B Peterson.   

Abstract

The World Health Organization (WHO) is responsible for providing evidence-based family planning guidance for use worldwide. WHO currently has two such guidelines, Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use, which are widely used globally and often incorporated into national family planning standards and guidelines. To ensure that these guidelines remain up-to-date, WHO, in collaboration with the Centers for Disease Control and Prevention and the Information and Knowledge for Optimal Health (INFO) Project at the Johns Hopkins Bloomberg School of Public Health's Center for Communication Programs, has developed the Continuous Identification of Research Evidence (CIRE) system to identify, synthesize, and evaluate new scientific evidence as it becomes available. The CIRE system identifies new evidence that is relevant to current WHO family planning recommendations through ongoing review of the input to the POPulation information onLINE (POPLINE) database. Using the Meta-Analysis of Observational Studies in Epidemiology guidelines and standardized abstract forms, systematic reviews are conducted, peer-reviewed, and sent to WHO for further action. Since the system began in October 2002, 90 relevant new articles have been identified, leading to 43 systematic reviews, which were used during the 2003-2004 revisions of WHO's family planning guidelines. The partnership developed to create and manage the CIRE system has pooled existing resources; scaled up the methodology for evaluating and synthesizing evidence, including a peer-review process; and provided WHO with finger-on-the-pulse capability to ensure that its family planning guidelines remain up-to-date and based on the best available evidence.

Mesh:

Year:  2005        PMID: 15894153     DOI: 10.1016/j.amepre.2005.02.008

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  12 in total

1.  Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial.

Authors:  Othman Kakaire; Josaphat Kayogoza Byamugisha; Nazarius Mbona Tumwesigye; Kristina Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2015-05-15       Impact factor: 6.918

Review 2.  Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review.

Authors:  Lauren B Zapata; Maria W Steenland; Dalia Brahmi; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2012-10-22       Impact factor: 3.375

Review 3.  When can a woman have an intrauterine device inserted? A systematic review.

Authors:  Maura K Whiteman; Crystal P Tyler; Suzanne G Folger; Mary E Gaffield; Kathryn M Curtis
Journal:  Contraception       Date:  2012-09-17       Impact factor: 3.375

Review 4.  The effect of follow-up visits or contacts after contraceptive initiation on method continuation and correct use.

Authors:  Maria W Steenland; Lauren B Zapata; Dalia Brahmi; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2012-10-29       Impact factor: 3.375

5.  Hormonal contraceptive methods and HIV: research gaps and programmatic priorities.

Authors:  Halley E M Riley; Petrus S Steyn; Sharon L Achilles; Emily Bass; Andrew L Gray; Chelsea B Polis; James N Kiarie
Journal:  Contraception       Date:  2017-06-07       Impact factor: 3.375

Review 6.  The WHO's medical eligibility criteria for contraceptive use: 20 years of global guidance.

Authors:  Anna L Altshuler; Mary E Gaffield; James N Kiarie
Journal:  Curr Opin Obstet Gynecol       Date:  2015-12       Impact factor: 1.927

7.  Prevalence and factors associated with sexually transmitted infections among HIV positive women opting for intrauterine contraception.

Authors:  Othman Kakaire; Josaphat Kayogoza Byamugisha; Nazarius Mbona Tumwesigye; Kristina Gamzell-Danielsson
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.

Authors:  Naomi K Tepper; Jamie W Krashin; Kathryn M Curtis; Shanna Cox; Maura K Whiteman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-22       Impact factor: 17.586

9.  Development, updates, and future directions of the World Health Organization Selected Practice Recommendations for Contraceptive Use.

Authors:  Melissa J Chen; Caron R Kim; Katherine C Whitehouse; Erin Berry-Bibee; Mary E Gaffield
Journal:  Int J Gynaecol Obstet       Date:  2016-12-13       Impact factor: 3.561

Review 10.  Outreach and integration programs to promote family planning in the extended postpartum period.

Authors:  Sarita Sonalkar; Sheila Mody; Mary E Gaffield
Journal:  Int J Gynaecol Obstet       Date:  2013-12-12       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.